198 related articles for article (PubMed ID: 27403534)
1. Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation.
Nakano Y; Matoba T; Tokutome M; Funamoto D; Katsuki S; Ikeda G; Nagaoka K; Ishikita A; Nakano K; Koga J; Sunagawa K; Egashira K
Sci Rep; 2016 Jul; 6():29601. PubMed ID: 27403534
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models.
Tokutome M; Matoba T; Nakano Y; Okahara A; Fujiwara M; Koga JI; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Feb; 115(2):419-431. PubMed ID: 30084995
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
[TBL] [Abstract][Full Text] [Related]
4. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model.
Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K
PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665
[TBL] [Abstract][Full Text] [Related]
5. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia-Reperfusion Injury.
Ikeda G; Matoba T; Ishikita A; Nagaoka K; Nakano K; Koga JI; Tsutsui H; Egashira K
J Am Heart Assoc; 2021 Jun; 10(12):e019521. PubMed ID: 34056918
[TBL] [Abstract][Full Text] [Related]
8. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.
Chang MY; Yang YJ; Chang CH; Tang AC; Liao WY; Cheng FY; Yeh CS; Lai JJ; Stayton PS; Hsieh PC
J Control Release; 2013 Sep; 170(2):287-94. PubMed ID: 23665256
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated Inflammation.
Mao Y; Koga JI; Tokutome M; Matoba T; Ikeda G; Nakano K; Egashira K
Int Heart J; 2017 Aug; 58(4):615-623. PubMed ID: 28701679
[TBL] [Abstract][Full Text] [Related]
11. Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning.
Pantos C; Paizis I; Mourouzis I; Moraitis P; Tzeis S; Karamanoli E; Mourouzis C; Karageorgiou H; Cokkinos DV
Horm Metab Res; 2005 Aug; 37(8):500-4. PubMed ID: 16138263
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
Jugdutt BI; Menon V
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):217-26. PubMed ID: 14506547
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury.
Ke D; Fang J; Fan L; Chen Z; Chen L
Coron Artery Dis; 2013 Jun; 24(4):334-41. PubMed ID: 23531479
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor blockade does not enhance apoptotic cell death during ischemia and reperfusion in humans in vivo.
Meijer P; Wouters CW; Oyen WJ; Boerman OC; Scheffer GJ; Smits P; Rongen GA
J Cardiovasc Pharmacol; 2011 Jun; 57(6):702-6. PubMed ID: 21423028
[TBL] [Abstract][Full Text] [Related]
15. Novel multiple agents loaded PLGA nanoparticles for brain delivery via inner ear administration: in vitro and in vivo evaluation.
Zhang X; Chen G; Wen L; Yang F; Shao AL; Li X; Long W; Mu L
Eur J Pharm Sci; 2013 Mar; 48(4-5):595-603. PubMed ID: 23354153
[TBL] [Abstract][Full Text] [Related]
16. Local delivery of a senolytic drug in ischemia and reperfusion-injured heart attenuates cardiac remodeling and restores impaired cardiac function.
Lee JR; Park BW; Park JH; Lim S; Kwon SP; Hwang JW; Kim H; Park HJ; Kim BS
Acta Biomater; 2021 Nov; 135():520-533. PubMed ID: 34454081
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
18. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
[TBL] [Abstract][Full Text] [Related]
19. Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
Messadi-Laribi E; Griol-Charhbili V; Pizard A; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
J Pharmacol Exp Ther; 2007 Oct; 323(1):210-6. PubMed ID: 17636004
[TBL] [Abstract][Full Text] [Related]
20. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Hartman JC
Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]